Firm Wire items are announcements made by the firms themselves. The desk confirms that the announcement was published and reproduces its factual content. It does not verify the claims in it, and publication is not an endorsement.
Troutman Pepper Locke says it published a paper on cell and gene therapy collaboration deals
Troutman Pepper Locke said it published a paper examining how cell and gene therapies affect collaboration agreements, licensing and manufacturing relationships. The firm said the paper connects scientific and manufacturing considerations with regulatory strategy, intellectual property and transaction terms, addressing responsibilities across development, commercialization and long-term follow-up.
Key points
- Troutman Pepper Locke identified EA Weeks as the author and Amanda Hassan, Heather Morehouse Ettinger, Judy O’Grady and Mindy Rudolph as contributors.Troutman Pepper Locke
- The firm said the paper distinguishes patient-specific manufacturing slots from volume-based capacity commitments.Troutman Pepper Locke
- Troutman Pepper Locke said the paper addresses technology transfer packages and step-in rights.Troutman Pepper Locke
- The firm said it discusses allocating data access and safety obligations that can continue for 10 to 15 years or more.Troutman Pepper Locke